Global Constipation Treatment Market Insights, Forecast to 2025
Table of Contents
1 Study Coverage
- 1.1 Constipation Treatment Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Constipation Treatment Market Size Growth Rate by Product
- 1.4.2 Chronic Idiopathic Constipation
- 1.4.3 Irritable Bowel Syndrome with Constipation
- 1.4.4 Opioid Induced Constipation
- 1.5 Market by End User
- 1.5.1 Global Constipation Treatment Market Size Growth Rate by End User
- 1.5.2 Hospital Pharmacies
- 1.5.3 Retail Pharmacies
- 1.5.4 Online Pharmacies
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Constipation Treatment Market Size
- 2.1.1 Global Constipation Treatment Revenue 2014-2025
- 2.1.2 Global Constipation Treatment Sales 2014-2025
- 2.2 Constipation Treatment Growth Rate by Regions
- 2.2.1 Global Constipation Treatment Sales by Regions
- 2.2.2 Global Constipation Treatment Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Constipation Treatment Sales by Manufacturers
- 3.1.1 Constipation Treatment Sales by Manufacturers
- 3.1.2 Constipation Treatment Sales Market Share by Manufacturers
- 3.1.3 Global Constipation Treatment Market Concentration Ratio (CR5 and HHI)
- 3.2 Constipation Treatment Revenue by Manufacturers
- 3.2.1 Constipation Treatment Revenue by Manufacturers (2014-2019)
- 3.2.2 Constipation Treatment Revenue Share by Manufacturers (2014-2019)
- 3.3 Constipation Treatment Price by Manufacturers
- 3.4 Constipation Treatment Manufacturing Base Distribution, Product Types
- 3.4.1 Constipation Treatment Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Constipation Treatment Product Type
- 3.4.3 Date of International Manufacturers Enter into Constipation Treatment Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Constipation Treatment Sales by Product
- 4.2 Global Constipation Treatment Revenue by Product
- 4.3 Constipation Treatment Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Constipation Treatment Breakdown Data by End User
6 North America
- 6.1 North America Constipation Treatment by Countries
- 6.1.1 North America Constipation Treatment Sales by Countries
- 6.1.2 North America Constipation Treatment Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Constipation Treatment by Product
- 6.3 North America Constipation Treatment by End User
7 Europe
- 7.1 Europe Constipation Treatment by Countries
- 7.1.1 Europe Constipation Treatment Sales by Countries
- 7.1.2 Europe Constipation Treatment Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Constipation Treatment by Product
- 7.3 Europe Constipation Treatment by End User
8 Asia Pacific
- 8.1 Asia Pacific Constipation Treatment by Countries
- 8.1.1 Asia Pacific Constipation Treatment Sales by Countries
- 8.1.2 Asia Pacific Constipation Treatment Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Constipation Treatment by Product
- 8.3 Asia Pacific Constipation Treatment by End User
9 Central & South America
- 9.1 Central & South America Constipation Treatment by Countries
- 9.1.1 Central & South America Constipation Treatment Sales by Countries
- 9.1.2 Central & South America Constipation Treatment Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Constipation Treatment by Product
- 9.3 Central & South America Constipation Treatment by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Constipation Treatment by Countries
- 10.1.1 Middle East and Africa Constipation Treatment Sales by Countries
- 10.1.2 Middle East and Africa Constipation Treatment Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Constipation Treatment by Product
- 10.3 Middle East and Africa Constipation Treatment by End User
11 Company Profiles
- 11.1 Takeda
- 11.1.1 Takeda Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Takeda Constipation Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Takeda Constipation Treatment Products Offered
- 11.1.5 Takeda Recent Development
- 11.2 SGYP
- 11.2.1 SGYP Company Details
- 11.2.2 Company Business Overview
- 11.2.3 SGYP Constipation Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 SGYP Constipation Treatment Products Offered
- 11.2.5 SGYP Recent Development
- 11.3 Sucampo Pharmaceuticals
- 11.3.1 Sucampo Pharmaceuticals Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Sucampo Pharmaceuticals Constipation Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Sucampo Pharmaceuticals Constipation Treatment Products Offered
- 11.3.5 Sucampo Pharmaceuticals Recent Development
- 11.4 Ironwood Pharmaceuticals
- 11.4.1 Ironwood Pharmaceuticals Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Ironwood Pharmaceuticals Constipation Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Ironwood Pharmaceuticals Constipation Treatment Products Offered
- 11.4.5 Ironwood Pharmaceuticals Recent Development
- 11.5 Abbott
- 11.5.1 Abbott Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Abbott Constipation Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Abbott Constipation Treatment Products Offered
- 11.5.5 Abbott Recent Development
- 11.6 AstraZeneca
- 11.6.1 AstraZeneca Company Details
- 11.6.2 Company Business Overview
- 11.6.3 AstraZeneca Constipation Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 AstraZeneca Constipation Treatment Products Offered
- 11.6.5 AstraZeneca Recent Development
- 11.7 Cosmo Pharmaceuticals
- 11.7.1 Cosmo Pharmaceuticals Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Cosmo Pharmaceuticals Constipation Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Cosmo Pharmaceuticals Constipation Treatment Products Offered
- 11.7.5 Cosmo Pharmaceuticals Recent Development
- 11.8 Sanofi
- 11.8.1 Sanofi Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Sanofi Constipation Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Sanofi Constipation Treatment Products Offered
- 11.8.5 Sanofi Recent Development
- 11.9 Daewoong
- 11.9.1 Daewoong Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Daewoong Constipation Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Daewoong Constipation Treatment Products Offered
- 11.9.5 Daewoong Recent Development
- 11.10 Bayer
- 11.10.1 Bayer Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Bayer Constipation Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Bayer Constipation Treatment Products Offered
- 11.10.5 Bayer Recent Development
- 11.11 Prestige Brands
- 11.12 Janssen Pharmaceutical
- 11.13 Shionogi
- 11.14 Albireo Pharma
- 11.15 Renexxion
12 Future Forecast
- 12.1 Constipation Treatment Market Forecast by Regions
- 12.1.1 Global Constipation Treatment Sales Forecast by Regions 2019-2025
- 12.1.2 Global Constipation Treatment Revenue Forecast by Regions 2019-2025
- 12.2 Constipation Treatment Market Forecast by Product
- 12.2.1 Global Constipation Treatment Sales Forecast by Product 2019-2025
- 12.2.2 Global Constipation Treatment Revenue Forecast by Product 2019-2025
- 12.3 Constipation Treatment Market Forecast by End User
- 12.4 North America Constipation Treatment Forecast
- 12.5 Europe Constipation Treatment Forecast
- 12.6 Asia Pacific Constipation Treatment Forecast
- 12.7 Central & South America Constipation Treatment Forecast
- 12.8 Middle East and Africa Constipation Treatment Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Constipation Treatment Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Constipation refers to bowel movements that are infrequent or hard to pass. The stool is often hard and dry. Other symptoms may include abdominal pain, bloating, and feeling as if one has not completely passed the bowel movement.
The global Constipation Treatment market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Constipation Treatment market based on company, product type, end user and key regions.
This report studies the global market size of Constipation Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Constipation Treatment in these regions.
This research report categorizes the global Constipation Treatment market by top players/brands, region, type and end user. This report also studies the global Constipation Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Takeda
SGYP
Sucampo Pharmaceuticals
Ironwood Pharmaceuticals
Abbott
AstraZeneca
Cosmo Pharmaceuticals
Sanofi
Daewoong
Bayer
Prestige Brands
Janssen Pharmaceutical
Shionogi
Albireo Pharma
Renexxion
Market size by Product
Chronic Idiopathic Constipation
Irritable Bowel Syndrome with Constipation
Opioid Induced Constipation
Market size by End User
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Constipation Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Constipation Treatment market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Constipation Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Constipation Treatment submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Constipation Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (Kg). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Constipation Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.